Dr. Amy Davis retweetledi

The same companies you say are denying claims, are the ones you prop up buying access to formularies.
Tell your members to stop being afraid of the PBMs and the insurance companies that own them, or they own.
Your members selling to distribution at WAC and making up categories of Class of Trade to protect PBMs , is costing patients billions per year. Making your medicines unaffordable to many.
I get that the PBMs can crush your sales with formulary manipulation, but if you truly care about patients , it’s time for you to stand up to them. Go to the DOJ and the FTC, tell them how it works.
Or maybe you want to be able to use rebates to buy market share and let patients die or get sicker because they can’t afford to pay list price.
The industry is broken. Stand up to it
PhRMA@PhRMA
On the Hill this week, we heard how insurers are standing between patients and care. New data shows 70% of patients are initially denied coverage for a prescribed medicine, delaying or preventing treatment. Patients should not face red tape. It is time to put them first. phrma.org/blog/briefing-…
English






















